Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery
03 juil. 2024 13h05 HE
|
Sharps Technology Inc
Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes First 100k unit shipment is scheduled...
Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
03 juil. 2024 10h55 HE
|
Sharps Technology Inc
All shareholders of record as of May 17, 2024 are eligible to vote Final votes must be cast by 11:59 p.m., Eastern Time on July 12, 2024 NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps...
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia
17 juin 2024 08h30 HE
|
Sharps Technology Inc
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class...
Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18
14 juin 2024 13h40 HE
|
Sharps Technology Inc
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class...
Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility
13 juin 2024 08h30 HE
|
Sharps Technology Inc
Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track...
Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit
05 juin 2024 08h30 HE
|
Sharps Technology Inc
InjectEZ acquisition establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. has progressed with the payment of $1 million into third-party escrow account. Closing on the...
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
31 mai 2024 08h30 HE
|
Sharps Technology Inc
Sharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. Signed Syringe Sales...
Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
30 mai 2024 08h30 HE
|
Sharps Technology Inc
Sharps will strengthen its manufacturing capacity with a $35 million acquisition of assets, establishing the Company’s position in the specialized copolymer prefillable syringe (PFS) system industry...
Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes
28 mai 2024 13h00 HE
|
Sharps Technology Inc
Sharps CEO issues letter to shareholders on FDA actions and tariffs affecting Chinese syringes. The FDA began raising quality concerns over Chinese-manufactured syringes in November 2023, resulting...
Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems
07 mars 2024 08h00 HE
|
Sharps Technology Inc
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class...